Cargando…

Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes

BACKGROUND: Interleukin-17 (IL-17) antagonism in rats reduces the severity and progression of AKI. IL-17-producing circulating T helper-17 (TH17) cells is increased in critically ill patients with AKI indicating that this pathway is also activated in humans. We aim to compare serum IL-17A levels in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collett, Jason A., Ortiz-Soriano, Victor, Li, Xilong, Flannery, Alexander H., Toto, Robert D., Moe, Orson W., Basile, David P., Neyra, Javier A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008961/ https://www.ncbi.nlm.nih.gov/pubmed/35422004 http://dx.doi.org/10.1186/s13054-022-03976-4

Ejemplares similares

Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study
por: Flannery, Alexander H., et al.
Publicado: (2021)

Urine Klotho Is Lower in Critically Ill Patients With Versus Without Acute Kidney Injury and Associates With Major Adverse Kidney Events
por: Neyra, Javier A., et al.
Publicado: (2019)

Impact of Acute Kidney Injury and CKD on Adverse Outcomes in Critically Ill Septic Patients
por: Neyra, Javier A., et al.
Publicado: (2018)

Sepsis-Associated Acute Kidney Disease and Long-term Kidney Outcomes
por: Flannery, Alexander H., et al.
Publicado: (2021)

Acute kidney injury contributes to worse physical and quality of life outcomes in survivors of critical illness
por: Mayer, Kirby P., et al.
Publicado: (2022)

A Survey Study of Self-Rated Patients’ Knowledge About AKI in a Post-Discharge AKI Clinic
por: Ortiz-Soriano, Victor, et al.
Publicado: (2019)

Global Perspectives in AKI: Peru
por: Herrera-Añazco, Percy, et al.
Publicado: (2023)

Nutrition Support in Critically Ill Patients with AKI
por: Ramakrishnan, Nagarajan, et al.
Publicado: (2020)

Survey of Current Practices of Outpatient Hemodialysis for AKI Patients
por: Ortiz-Soriano, Victor, et al.
Publicado: (2021)

Fluid accumulation increases the risk of AKI progression and death in critically ill patients with early AKI
por: Raimundo, MR, et al.
Publicado: (2014)

Hepatic drug metabolism by CYP2D6 in critically ill adults with AKI: effect of phenotype and AKI severity
por: Lane, K, et al.
Publicado: (2015)

Evaluation of Factors Associated with Hypermetabolism and Hypometabolism in Critically Ill AKI Patients
por: de Góes, Cassiana R., et al.
Publicado: (2018)

Urine Complement Factor Ba Is Associated with AKI in Critically Ill Children
por: Stenson, Erin K., et al.
Publicado: (2023)

Epidemiology and Outcomes of AKI Treated With Continuous Kidney Replacement Therapy: The Multicenter CRRTnet Study
por: Rewa, Oleksa G., et al.
Publicado: (2023)

Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients
por: Ghasemiyeh, Parisa, et al.
Publicado: (2023)

Hypochloraemia and Worse Clinical Outcome in Critically Ill Patients
por: Gatz, Rainer, et al.
Publicado: (2012)

AKI patients have worse long-term outcomes, especially in the immediate post-ICU period
por: Hoste, Eric AJ, et al.
Publicado: (2012)

Kidney Tubular Damage and Functional Biomarkers in Acute Kidney Injury Following Cardiac Surgery
por: Neyra, Javier A., et al.
Publicado: (2019)

Impact of ideal versus estimated body weight on haemofiltration dosing in critically ill patients with AKI
por: Fischer, F, et al.
Publicado: (2014)

ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
por: Truche, A. S., et al.
Publicado: (2018)

Neurological Impairment in Critically Ill Patients on Dialysis: Research Letter for the INCOGNITO-AKI Feasibility Study
por: Jawa, Natasha A., et al.
Publicado: (2023)

Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012)

Sputum “IL-5, IL-17A, IL-25-high” pattern is associated with uncontrolled asthma and worse lung function
por: Seys, Sven, et al.
Publicado: (2013)

Preparedness of Kidney Replacement Therapy in the Critically Ill During COVID-19 Surge
por: Neyra, Javier A., et al.
Publicado: (2020)

Predictors of renal recovery in critically ill patients with AKI: observations from the ongoing FBI clinical trial
por: Robinson, S, et al.
Publicado: (2015)

Urinary TIMP-2 and IGFBP7 elevate early in critically ill postoperative patients that develop AKI
por: Honore, P, et al.
Publicado: (2015)

The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill
por: Knight, Jennifer M., et al.
Publicado: (2021)

IL-18 deficiency ameliorates the progression from AKI to CKD
por: Luan, Junjun, et al.
Publicado: (2022)

Urine pH and Citrate as Predictors of Calcium Phosphate Stone Formation
por: Adomako, Emmanuel A., et al.
Publicado: (2023)

AKI-CLIF-SOFA: a novel prognostic score for critically ill cirrhotic patients with acute kidney injury
por: Sun, Dan-Qin, et al.
Publicado: (2017)

Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria
por: Koeze, J., et al.
Publicado: (2017)

POS-027 Critical illness and systemic inflammation are key risk factors of severe AKI in patients with COVID-19
por: HARDENBERG, J.H.B., et al.
Publicado: (2021)

Relationship between CRP Albumin Ratio and the Mortality in Critically Ill Patients with AKI: A Retrospective Observational Study
por: Wang, Jiajia, et al.
Publicado: (2021)

Serum Magnesium Levels and Cardiovascular Outcomes in Systolic Blood Pressure Intervention Trial Participants
por: Ferrè, Silvia, et al.
Publicado: (2023)

Characteristics and Outcomes of Survivors of Critical Illness and Acute Kidney Injury Followed in a Pilot Acute Kidney Injury Clinic
por: Ly, Han, et al.
Publicado: (2021)

Global Perspectives in AKI: Argentina
por: De Arteaga, Javier, et al.
Publicado: (2023)

The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients
por: Khawaja, Shabnum, et al.
Publicado: (2019)

Performance of soluble Klotho assays in clinical samples of kidney disease
por: Neyra, Javier A, et al.
Publicado: (2019)

Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)

Latent AKI is… still AKI: the quantification of the burden of renal dysfunction
por: Ricci, Zaccaria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3qg2nkbadaq0o2op0gslfcjv4u